|
|
|
|
Return to Savvy Consumer Information Center - Home Page |
Efficacy rates in this chart are based on Contraceptive Technology (16th edition, 1994). They are yearly estimates of effectiveness in typical use, which refers to a method's reliability in real life, when people don't always use a method properly. For comparison, about 85 percent of sexually active women using no contraception would be expected to become pregnant in a year.
This chart is a summary; it is not intended to be used alone. All product labeling should be followed carefully, and a health-care professional should be consulted for some methods.
Estimated Effectiveness: 88% (a)
Some
Risks (d): Irritation and allergic reactions (less likely with
polyurethane)
Protection from Sexually Transmitted Diseases
(STDs): Except for abstinence, latex condoms are the best
protection against STDs, including herpes and AIDS.
Convenience:
Applied immediately before intercourse; used only once and discarded.
Availability: Nonprescription
Estimated Effectiveness: 79%
Some Risks
(d): Irritation and allergic reactions
Protection
from Sexually Transmitted Diseases (STDs): May give some STD
protection; not as effective as latex condom.
Convenience:
Applied immediately before intercourse; used only once and discarded.
Availability: Nonprescription
Estimated Effectiveness: 82%
Some Risks
(d): Irritation and allergic reactions, urinary tract infection
Protection from Sexually Transmitted Diseases (STDs):
Protects against cervical infection; spermicide may give some protection
against chlamydia and gonorrhea; otherwise unknown.
Convenience:
Inserted before intercourse and left in place at least six hours after;
can be left in place for 24 hours, with additional spermicide for repeated
intercourse.
Availability: Prescription
Estimated Effectiveness: 64-82% (b)
Some
Risks (d): Irritation and allergic reactions, abnormal Pap test
Protection from Sexually Transmitted Diseases (STDs):
Spermicide may give some protection against chlamydia and gonorrhea;
otherwise unknown.
Convenience: May be difficult to
insert; can remain in place for 48 hours without reapplying spermicide for
repeated intercourse.
Availability: Prescription
Estimated Effectiveness: 64-82% (b)
Some
Risks (d): Irritation and allergic reactions, difficulty in
removal
Protection from Sexually Transmitted Diseases
(STDs): Spermicide may give some protection against chlamydia and
gonorrhea; otherwise unknown.
Convenience: Inserted
before intercourse and protects for 24 hours without additional
spermicide; must be left in place for at least six hours after
intercourse; must be removed within 30 hours of insertion; used only once
and discarded.
Availability: Nonprescription; not
currently marketed.
Estimated Effectiveness: 79%
Some Risks
(d): Irritation and allergic reactions
Protection
from Sexually Transmitted Diseases (STDs): May give some
protection against chlamydia and gonorrhea; otherwise unknown.
Convenience: Instructions vary; usually applied no more
than one hour before intercourse and left in place at least six to eight
hours after.
Availability: Nonprescription
Estimated Effectiveness: Over 99% (c)
Some
Risks (d): Dizziness; nausea; changes in menstruation, mood, and
weight; rarely cardiovascular disease, including high blood pressure,
blood clots, heart attack, and strokes
Protection from
Sexually Transmitted Diseases (STDs): None, except some
protection against pelvic inflammatory disease.
Convenience:
Must be taken on daily schedule, regardless of frequency of intercourse.
Availability: Prescription
Estimated Effectiveness: Over 99% (c)
Some
Risks (d): Ectopic pregnancy, irregular bleeding, weight gain,
breast tenderness
Protection from Sexually Transmitted
Diseases (STDs): None, except some protection against pelvic
inflammatory disease.
Convenience: Must be taken on
daily schedule, regardless of frequency of intercourse.
Availability:
Prescription
Estimated Effectiveness: Over 99%
Some
Risks (d): Irregular bleeding, weight gain, breast tenderness,
headaches
Protection from Sexually Transmitted Diseases
(STDs): None
Convenience: One injection
every three months
Availability: Prescription
Estimated Effectiveness: Over 99%
Some
Risks (d): Irregular bleeding, weight gain, breast tenderness,
headaches, difficulty in removal
Protection from Sexually
Transmitted Diseases (STDs): None
Convenience:
Implanted by health-care provider--minor outpatient surgical procedure;
effective for up to five years.
Availability:
Prescription
Estimated Effectiveness: 98-99%
Some
Risks (d): Cramps, bleeding, pelvic inflammatory disease,
infertility, perforation of uterus
Protection from Sexually
Transmitted Diseases (STDs): None
Convenience:
After insertion by physician, can remain in place for up to one or 10
years, depending on type.
Availability:
Prescription
Estimated Effectiveness: About 80% (variable, based on
method)
Some Risks (d): None
Protection
from Sexually Transmitted Diseases (STDs): None
Convenience:
Requires frequent monitoring of body functions (for example, body
temperature for one method).
Availability:
Instructions from health-care provider
Estimated Effectiveness: Over 99%
Some
Risks (d): Pain, bleeding, infection, other minor postsurgical
complications
Protection from Sexually Transmitted Diseases
(STDs): None
Convenience: One-time
surgical procedure
Availability: Surgery
(a) Effectiveness rate for polyurethane condoms has not been established.
(b) Less effective for women who have had a baby because the birth process stretches the vagina and cervix, making it more difficult to achieve a proper fit.
(c) Based on perfect use, when the woman takes the pill every day as directed.
(d) Serious medical risks from contraceptives are rare.
FDA Consumer magazine (April 1997)
Return to Savvy Consumer Information Center - Home Page |
|
|
|
|
Get the Savvy Consumer Newsletter! (FREE) |